Position in MRNA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$479,304,705
+$207,417,405 QoQ
Shares Held
9,435,132
+2.3% QoQ
Ownership
2.38%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.9276533704033.ToString("F0")%
Shared 0.ToString("F0")%
None 0.07234662959670304.ToString("F0")%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,556,641,344 across 524 Biotechnology names. MRNA ranks #5 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
This page
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $479,304,705 | 9,435,132 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $271,887,300 | 9,219,644 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $238,910,762 | 9,249,352 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $244,924,155 | 8,877,280 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $211,394,325 | 7,456,590 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $301,095,498 | 7,241,354 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $472,460,031 | 7,069,580 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $818,361,468 | 6,891,465 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $719,331,042 | 6,750,479 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $651,343,896 | 6,549,461 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $662,606,279 | 6,415,009 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $765,753,385 | 6,302,497 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $959,100,496 | 6,244,957 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,107,840,837 | 6,167,692 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $738,803,650 | 6,247,811 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $905,339,159 | 6,337,691 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $1,108,726,340 | 6,436,354 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,532,124,952 | 6,032,463 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,216,778,590 | 5,759,961 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $788,559,512 | 3,355,858 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $498,452,008 | 3,806,430 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $373,087,442 | 3,571,240 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $238,058,538 | 3,364,785 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $213,693,191 | 3,328,036 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $79,481,879 | 2,653,819 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||